Previous studies as described below have demonstrated that histone acetylation regulates NKG2D ligand expression such as MICA, MICB, and ULBPs, which are critical for the activation of natural killer (NK) cells and immune surveillance against cancer cells. The gene discussed is MICB; the disease is cancer.